Shalby Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Attractively valued vs sector (P/E 41.9x vs industry 54.7x)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
SHALBY · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 74.12% | 74.24% | 74.25% | 74.25% | 74.27% | 74.27% |
| FII | 4.62% | 4.88% | 5.35% | 5.37% | 4.65% | 4.54% |
| DII | — | — | 0.06% | 0.09% | 0.14% | 0.18% |
| Public | 20.42% | 20.13% | 19.65% | 19.59% | 20.26% | 20.33% |
| Others | 0.83% | 0.76% | 0.70% | 0.69% | 0.69% | 0.69% |
Latest News
All newsShalby informs shareholders about AGM and annual report access
*Shalby informs shareholders about AGM and annual report access*. Shalby Limited has notified shareholders without registered email IDs to access the **Annual Report FY 2025-26** and **Notice of 22nd AGM** via a specified web link. This is a routine corporate communication ahead of the annual general meeting. No financial or operational updates were disclosed. 📊 *STOCKS:* $SHALBY | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #AGM
Shalby shares unchanged after investor meet updates
*Shalby shares unchanged after investor meet updates.* The company shared recording of its recent Analyst/Institutional Investor meet. No **new financial guidance** or major announcements were disclosed. The update primarily covered business performance and strategy. 📊 *STOCKS:* $SHALBY | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #InvestorMeet